For both assessed RCC subtypes, these three CBXs presented a similar profile: CBX3/6/7 showed the highest rates of genetic alteration, CBX3 mRNA level was upregulated, CBX6/7 associated with tumor stage, and CBX7 also associated with better prognosis. This evidence concerns the gene CBX7 and renal cell carcinoma.